Amneal Pharmaceuticals, Inc. ( AMRX) - Key Metrics
AMRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $2.57 | -$0.02 | $0.30 | $0.18 |
| 2026Q2 | $2.49 | $0.18 | -$0.06 | -$0.20 |
| 2026Q1 | $2.29 | $0.20 | -$0.09 | -$0.13 |
| 2025Q4 | $2.60 | $0.11 | $0.42 | $0.28 |
| 2025Q3 | $2.50 | $0.01 | $0.38 | $0.33 |
AMRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -83.92 |
| 2026Q2 | 0% | 24.04 |
| 2026Q1 | 0% | 15.54 |
| 2025Q4 | 0% | 28.64 |
| 2025Q3 | 0% | 333.67 |
AMRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.90% | 0% |
| 2026Q2 | -1.17% | 0% |
| 2026Q1 | -1.08% | 0% |
| 2025Q4 | 2.21% | 0% |
| 2025Q3 | 3.29% | 0% |
AMRX
Price: $21.40
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.40 USD
P/E Ratio: 53.20
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.8 million
Market Capitalization: 7.4 billion